203.785.2862

Professor of Public Health and Management Sciences

Professor Paltiel aims to promote a reasoned approach to choices in the health sector. An expert in the field of pharmacoeconomics and disease modeling, he has published on the cost-effectiveness of a variety of medical technologies, pharmaceutical products, and public health activities. He has advised both industry and government on issues of health resource allocation and decision making. Professor Paltiel is the recipient of research grant support from the National Institute on Mental Health, the National Institute on Drug Abuse, and the National Institute of Allergy and Infectious Diseases.

Consultancies
Institute of Medicine
Brigham and Women’s Hospital
Massachusetts General Hospital
Weill Medical College of Cornell University

Achievements and Honors
Institute of Medicine, Committee on Valuing Community-Based, Non-Clinical Prevention Policies and Wellness Strategies, 2011-
Scientific Advisory Committee, French National Agency for Research on AIDS (ANRS), 2009-
Institute of Medicine, Committee on Review of Priorities in the National Vaccine Plan, 2008-2009
Institute of Medicine, Committee on Community Mitigation Strategies for Influenza Pandemic, 2006-2007
Institute of Medicine, Committee on the President's Emergency Plan for AIDS Relief (PEPFAR), 2005-2007
Institute of Medicine, Committee on the Ryan White CARE Act: Planning and Evaluation, 2002-2003
Society for Medical Decision Making, Secretary-Treasurer and Executive Committee member, 2006-

Selected Articles
"Economic Evaluation of Dengue Vector Control Strategies in an Urban Setting" (with P.M. Luz, T. Vanni, J. Medlock, and A.P. Galvani), The Lancet, 2011

"Projected Survival Gains from Revising State Laws Requiring Written Opt-in Consent for HIV Testing" (with M.D. April, J.J. Chiosi, P.E. Sax, and R.P. Walensky), Journal of General Internal Medicine, 2011

"Expanded HIV Screening in the U.S.: What Will It Cost Government Discretionary and Entitlement Programs? A Budget Impact Analysis" (with E.G. Martin, R.P. Walensky, and B.R. Schackman), Value in Health, 2010

"Are We Studying What Matters? Health Priorities and NIH-Funded Biomedical Engineering Research" (with J.B. Rubin and W.M. Saltzman), Annals of Biomedical Engineering, 2010

"Price, Performance, and the FDA Approval Process: The Example of Home HIV Testing" (with H.A. Pollack), Medical Decision Making, 2010

Education
PhD Yale University, 1992
MBA Yale University, 1985
BA McGill University, 1981